United States · FDA National Drug Code directory
LANREOTIDE ACETATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-907_6d47aa22-362a-4663-8b98-a16c4ff0607a
- Product NDC
- 69097-907
- Form
- INJECTION
- Composition / generic term
- LANREOTIDE ACETATE
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250530
- Source listing expiry
- 20261231
Source-listed ingredients
- LANREOTIDE ACETATE — 60 mg/.2mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 POUCH in 1 CARTON (69097-907-67) / 1 SYRINGE in 1 POUCH / .2 mL in 1 SYRINGE · 69097-907-67
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →